Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Solvents in MDI Production

Posted on By

SOP for Use of Solvents in MDI Production

Solvent Handling Procedures in MDI Production

1) Purpose

The purpose of this SOP is to establish procedures for the safe handling and use of solvents in metered-dose inhaler (MDI) production to ensure operator safety, product quality, and compliance with regulatory requirements.

2) Scope

This SOP applies to all personnel involved in the handling and use of solvents within the MDI production facility, including production operators, chemical engineers, and safety officers.

3) Responsibilities

The responsibilities for this SOP include handling solvents safely, monitoring usage levels, conducting risk assessments, and ensuring compliance with safety protocols. Specific roles include:
Production Operators: Handle and dispense solvents according to approved procedures.
Chemical Engineers: Assess solvent compatibility and conduct risk assessments.
Safety Officers: Monitor safety protocols and provide training on solvent handling procedures.

See also  SOP for Equipment Troubleshooting in MDI Production

4) Procedure

4.1 Solvent Storage and Handling
4.1.1 Store solvents in designated areas with appropriate ventilation and safety equipment.
4.1.2 Use compatible containers and dispensing equipment to minimize exposure and spills.
4.2 Solvent Addition to Formulations
4.2.1 Add solvents to MDI formulations using calibrated equipment and controlled dispensing methods.
4.2.2 Ensure thorough mixing and dispersion of solvents within

the formulation.
4.3 Safety Precautions
4.3.1 Wear appropriate PPE (Personal Protective Equipment) during solvent handling operations.
4.3.2 Implement fire safety measures and emergency response procedures for solvent spills or accidents.
4.4 Documentation
4.4.1 Maintain records of solvent handling procedures, including safety inspections and incident reports.
4.4.2 Document training records for personnel involved in solvent handling activities.

See also  SOP for Use of Propellants in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
SOP: Standard Operating Procedure
PPE: Personal Protective Equipment

6) Documents, if any

Solvent handling protocols, safety data sheets (SDS) for solvents, risk assessment reports, and training records should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and OSHA for solvent handling and safety requirements in pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Ring Quality Inspection Unit
Next Post: SOP for Homogeneity Testing in Granules

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version